↓ Skip to main content

Dove Medical Press

Article Metrics

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
71 Mendeley
Title
New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
Published in
Therapeutics and Clinical Risk Management, June 2014
DOI 10.2147/tcrm.s49063
Pubmed ID
Authors

Grigoris Gerotziafas, Isabelle Mahé, Ismail Elalamy

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Hungary 1 1%
Denmark 1 1%
Slovenia 1 1%
Unknown 67 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 21%
Student > Master 10 14%
Other 9 13%
Student > Postgraduate 7 10%
Student > Bachelor 7 10%
Other 14 20%
Unknown 9 13%
Readers by discipline Count As %
Medicine and Dentistry 35 49%
Pharmacology, Toxicology and Pharmaceutical Science 8 11%
Agricultural and Biological Sciences 5 7%
Economics, Econometrics and Finance 3 4%
Psychology 2 3%
Other 8 11%
Unknown 10 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2015.
All research outputs
#2,388,475
of 5,364,494 outputs
Outputs from Therapeutics and Clinical Risk Management
#211
of 545 outputs
Outputs of similar age
#50,740
of 129,227 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#6
of 18 outputs
Altmetric has tracked 5,364,494 research outputs across all sources so far. This one has received more attention than most of these and is in the 54th percentile.
So far Altmetric has tracked 545 research outputs from this source. They receive a mean Attention Score of 3.2. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 129,227 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.